Literature DB >> 15076292

Predictors of prostate cancer after initial negative systematic 12 core biopsy.

Herb Singh1, Eduardo I Canto, Shahrokh F Shariat, Dov Kadmon, Brian J Miles, Thomas M Wheeler, Kevin M Slawin.   

Abstract

PURPOSE: We determined the cancer detection rate at initial systematic 12 core (S12C) biopsy and identified features associated with cancer at repeat S12C biopsy after an initial negative S12C biopsy in patients with prostate specific antigen (PSA) parameters associated with a higher risk of prostate cancer.
MATERIALS AND METHODS: Between February 1999 and June 2002, 841 patients underwent initial S12C biopsy. Of these patients 99 underwent repeat S12C biopsy after initial negative S12C because of a percent free-to-total PSA of 15.0 or less and/or a yearly PSA velocity of 0.75 ng/ml or greater. The association between parameters revealed by initial biopsy and cancer at repeat biopsy was assessed.
RESULTS: Of the 99 patients 21 (21.2%) had cancer at repeat biopsy. Age (p = 0.01), PSA transitional zone density (p = 0.05), and high grade PIN at initial biopsy (p = 0.01) were associated with cancer at repeat biopsy.
CONCLUSIONS: In this select group of patients with PSA parameters associated with a higher risk of prostate cancer the cancer detection rate after initially negative S12C biopsy was 21%. Patients with high grade PIN on initial biopsy, advanced age and higher PSA transition zone density are at increased risk for cancer at repeat biopsy. Larger prospective studies are required to confirm these results and construct a nomogram that determines the probability of finding prostate cancer at subsequent biopsy.

Entities:  

Mesh:

Year:  2004        PMID: 15076292     DOI: 10.1097/01.ju.0000119667.86071.e7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  25 in total

1.  Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies.

Authors:  Bruce J Trock; Michelle J Brotzman; Leslie A Mangold; Joseph W Bigley; Jonathan I Epstein; David McLeod; Eric A Klein; J Stephen Jones; Songbai Wang; Theresa McAskill; Jyoti Mehrotra; Bhargavi Raghavan; Alan W Partin
Journal:  BJU Int       Date:  2011-11-11       Impact factor: 5.588

2.  Risk factors for prostate cancer detection after a negative biopsy: a novel multivariable longitudinal approach.

Authors:  Peter H Gann; Angela Fought; Ryan Deaton; William J Catalona; Edward Vonesh
Journal:  J Clin Oncol       Date:  2010-02-22       Impact factor: 44.544

Review 3.  Anatomic and Molecular Imaging in Prostate Cancer.

Authors:  Eric T Miller; Amirali Salmasi; Robert E Reiter
Journal:  Cold Spring Harb Perspect Med       Date:  2018-03-01       Impact factor: 6.915

4.  Using biopsy to detect prostate cancer.

Authors:  Shahrokh F Shariat; Claus G Roehrborn
Journal:  Rev Urol       Date:  2008

Review 5.  Internal Fusion: exact correlation of transrectal ultrasound images of the prostate by detailed landmarks over time for targeted biopsies or follow-up.

Authors:  Yanqi Xie; Theodoros Tokas; Björn Grabski; Tillmann Loch
Journal:  World J Urol       Date:  2017-12-27       Impact factor: 4.226

6.  The feasibility of assessing branched-chain amino acid metabolism in cellular models of prostate cancer with hyperpolarized [1-(13)C]-ketoisocaproate.

Authors:  Kelvin L Billingsley; Jae Mo Park; Sonal Josan; Ralph Hurd; Dirk Mayer; Eleanor Spielman-Sun; Dwight G Nishimura; James D Brooks; Daniel Spielman
Journal:  Magn Reson Imaging       Date:  2014-04-28       Impact factor: 2.546

7.  Molecular imaging of cholinergic processes in prostate cancer using ¹¹C-donepezil and ¹⁸F-FEOBV.

Authors:  Morten Gersel Stokholm; Søren Høyer; Michael Borre; Dirk Bender; Steen Jakobsen; Jørgen Frøkiær; Per Borghammer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-08-01       Impact factor: 9.236

8.  Development and validation of risk score for predicting positive repeat prostate biopsy in patients with a previous negative biopsy in a UK population.

Authors:  Mark A Rochester; Nora Pashayan; Fiona Matthews; Andrew Doble; John McLoughlin
Journal:  BMC Urol       Date:  2009-07-16       Impact factor: 2.264

9.  Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting.

Authors:  A V Taira; G S Merrick; R W Galbreath; H Andreini; W Taubenslag; R Curtis; W M Butler; E Adamovich; K E Wallner
Journal:  Prostate Cancer Prostatic Dis       Date:  2009-09-29       Impact factor: 5.554

10.  Prostate cancer detection at rebiopsy after an initial benign diagnosis: results using sextant extended prostate biopsy.

Authors:  Katia Ramos Moreira Leite; Luiz Heraldo Camara-Lopes; José Cury; Marcos F Dall'oglio; Adriana Sañudo; Miguel Srougi
Journal:  Clinics (Sao Paulo)       Date:  2008-06       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.